Randomized controlled trial of escitalopram versus placebo for patients with irritable bowel syndrome and panic disorder
Latest Information Update: 21 Dec 2023
At a glance
- Drugs Escitalopram (Primary)
- Indications Irritable bowel syndrome; Panic disorder
- Focus Therapeutic Use
Most Recent Events
- 12 Mar 2012 Planned end date changed from 30 Sep 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 12 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 12 Mar 2012 New source identified and integrated (NCT01551225; ClinicalTrials.gov: US National Institutes of Health).